How can I use a sterile fill-finish CDMO to support drug product final fill and finish?

A sterile fill-finish CDMO can support the final drug product stage by taking your formulated drug substance and aseptically filling it into its final container, then completing the steps needed for a market-ready product.

What they typically do

A sterile fill-finish CDMO may provide:

• Aseptic filling into vials, syringes, cartridges, or other containers
• Lyophilization (freeze-drying) if your product needs it
• Stoppering, capping, and sealing
• Container closure integrity support
• Visual inspection
• Labeling and packaging
• Cold-chain handling and storage
• Batch documentation and release support
• Stability and analytical support, depending on the provider

How to use one effectively

1. Define your product requirements

   • Dosage form
   • Container type and fill volume
   • Sterility and contamination control needs
   • Sensitivity to temperature, light, oxygen, or shear
   • Whether the product requires lyophilization

2. Assess CDMO capabilities

   • Aseptic processing experience
   • Compatible isolators/RABS
   • Fill line scale and throughput
   • Regulatory track record
   • Experience with your molecule type, such as biologics, small molecules, or injectables
   • Ability to handle your required container format

3. Transfer the process

   • Share formulation and process data
   • Run engineering and qualification batches
   • Establish aseptic process parameters
   • Validate cleaning, sterilization, and fill accuracy

4. Plan quality and regulatory work

   • Align on GMP responsibilities
   • Review batch records, specs, and release criteria
   • Confirm validation strategy
   • Prepare for audits and inspections

5. Scale from clinical to commercial

   • Start with small-scale or clinical fills
   • Move to process characterization and validation
   • Transition to commercial production once performance is proven

Benefits of using a fill-finish CDMO

• Faster route to clinic or market
• Access to specialized sterile manufacturing infrastructure
• Lower capital investment than building your own facility
• Regulatory and technical expertise
• Flexibility for pilot, clinical, and commercial batches

Key questions to ask a CDMO

• What sterile fill-finish modalities do you support?
• What are your batch sizes and minimum/maximum fill volumes?
• Do you support lyophilized or liquid products?
• What aseptic technologies do you use?
• What regulatory filings and markets have you supported?
• Can you handle my container closure system?
• What are your lead times and tech transfer requirements?

If you want, I can also help you with a CDMO selection checklist, a fill-finish RFP template, or a step-by-step tech transfer plan.